Search Results - Sherman, Macarena

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Immunomodulation of T Helper Cells by Tumor Microenvironment in Oral Cancer Is Associated With CCR8 Expression and Rapid Membrane Vitamin D Signaling Pathway

    Immunomodulation of T Helper Cells by Tumor Microenvironment in Oral Cancer Is Associated With CCR8 Expression and Rapid Membrane Vitamin D Signaling Pathway by Fraga, Marco, Yáñez, Milly, Sherman, Macarena, Llerena, Faryd, Hernandez, Mauricio, Nourdin, Guillermo, Álvarez, Francisco, Urrizola, Joaquín, Rivera, César, Lamperti, Liliana, Nova, Lorena, Castro, Silvia, Zambrano, Omar, Cifuentes, Alejandro, Campos, León, Moya, Sergio, Pastor, Juan, Nuñez, Marcelo, Gatica, Jorge, Figueroa, Jorge, Zúñiga, Felipe, Salomón, Carlos, Cerda, Gustavo, Puentes, Ricardo, Labarca, Gonzalo, Vidal, Mabel, McGregor, Reuben, Nova-Lamperti, Estefania

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    NOONAN SYNDROME WITH MULTIPLE GIANT CELL LESIONS, CASE REPORT

    NOONAN SYNDROME WITH MULTIPLE GIANT CELL LESIONS, CASE REPORT by ALLENDORF, MACARENA SHERMAN, OSSES, VICTOR RIVAS, SALAS, CAMILA DELGADO

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    NEUROFIBROMATOSIS TYPE 1 INVOLVING THE UPPER MAXILLA, CASE REPORT

    NEUROFIBROMATOSIS TYPE 1 INVOLVING THE UPPER MAXILLA, CASE REPORT by ALLENDORF, MACARENA SHERMAN, MUNZENMAYER, JUAN, SALAS, CAMILA DELGADO

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    ODONTOGENIC MYXOMA

    ODONTOGENIC MYXOMA by BEQUER, CONSTANZA ULLOA, ALLENDORF, MACARENA SHERMAN, SANCHEZ, JUAN PABLO BRITO, RODRIGUEZ, MAURICIO CARRASCO, MORALES, JUAN CARLOS PASTOR, ROA, ANA MARÍA SALAZAR, GONZÁLEZ, PAULINA CUBILLOS

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    CTNI-76. EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394) IN RECURRENT, PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)

    CTNI-76. EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394) IN RECURRENT, PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST) by de la Fuente, Macarena, Butowski, Nicholas, Taylor, Jennie, Yaeger, Rona, Tsai, Frank Yung-Chin, Janku, Filip, Allen, Carl, Ammakkanavar, Natraj, Michelson, Glenn, Jiang, Ping, Paz, Michael, Tussay-Lindenberg, Alexia, Wang, Kongming, Shepherd, Stacie Peacock, Kline, Irina, Sherman, Eric, Rodon, Jordi

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF

    Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF by Janku, Filip, Sherman, Eric, Yaeger, Rona, Parikh, Aparna, Sullivan, Ryan, Feun, Lynn, Fuente, Macarena De La, Tsai, Frank Yung-Chin, Gordon, Michael, Allen, Carl, Rudoltz, Marc S., Balinski, Kathe, Averbuch, Steven, Vidne, Michael, Tarcic, Gabi

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    TRLS-02. SAFETY AND EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394; PLX8394) IN CHILDREN AND ADULTS WITH RECURRENT, BRAF-ALTERED PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)

    TRLS-02. SAFETY AND EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394; PLX8394) IN CHILDREN AND ADULTS WITH RECURRENT, BRAF-ALTERED PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST) by de la Fuente, Macarena, Butowski, Nicholas A, Taylor, Jennie, Yaeger, Rona, Tsai, Frank Y-C, Janku, Filip, Allen, Carl E, Ammakkanavar, Natraj, Michelson, Glenn, Jiang, Ping, Samara, Emil, Paz, Michael, Tussay-Lindenberg, Alexia, Wang, Kongming, Shepherd, Stacie P, Kline, Irina, Sherman, Eric, Rodon, Jordi

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

    LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA by Mellinghoff, Ingo K, Cloughesy, Timothy, Alexander, Brian, Berry, Donald A, Buxton, Meredith, Cavenee, Webster, Colman, Howard, de Groot, John, Ellingson, Benjamin M, Gordon, Gary B, Lassman, Andrew B, Lim, Michael, Khasraw, Mustafa, Perry, James, Sulman, Erik P, Weller, Michael, Wen, Patrick, Yung, W K Alfred, Berry, Nicholas, Graves, Todd, Detry, Michelle, Hyddmark, E M Viktoria, Johnsson, Adam, Kling, Heather, McGlothlin, Anna, Powell, Ashley, Untch, Sarah, Aquilanti, Elisa, Blondin, Nicholas, Boulmay, Brian, de la Fuente, Macarena, Drappatz, Jan, Jordan, Justin, Kaley, Thomas J, Lobbous, Mina, Mikkelsen, Tom, Newton, Herbert, Owen, Scott, Peters, Katherine, Schiff, David, Sherman, Wendy, Weathers, Shiao-Pei, Youssef, Michael, Friend, John, Lee, Eudocia

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Lead Optimization toward Proof-of-Concept Tools for Huntington’s Disease within a 4‑(1H‑Pyrazol-4-yl)pyrimidine Class of Pan-JNK Inhibitors

    Lead Optimization toward Proof-of-Concept Tools for Huntington’s Disease within a 4‑(1H‑Pyrazol-4-yl)pyrimidine Class of Pan-JNK Inhibitors by Wityak, John, McGee, Kevin F, Conlon, Michael P, Song, Ren Hua, Duffy, Bryan C, Clayton, Brent, Lynch, Michael, Wang, Gwen, Freeman, Emily, Haber, James, Kitchen, Douglas B, Manning, David D, Ismail, Jiffry, Khmelnitsky, Yuri, Michels, Peter, Webster, Jeff, Irigoyen, Macarena, Luche, Michele, Hultman, Monica, Bai, Mei, Kuok, IokTeng D, Newell, Ryan, Lamers, Marieke, Leonard, Philip, Yates, Dawn, Matthews, Kim, Ongeri, Lynette, Clifton, Steve, Mead, Tania, Deupree, Susan, Wheelan, Pat, Lyons, Kathy, Wilson, Claire, Kiselyov, Alex, Toledo-Sherman, Leticia, Beconi, Maria, Muñoz-Sanjuan, Ignacio, Bard, Jonathan, Dominguez, Celia

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: